Recital 9, Regulation (EU) 2026/859

In forcesince 20 Apr 2026

As 2,4-DNT is a non-threshold carcinogen for which no DNEL can be derived, the dossier concluded that 2,4-DNT incorporated in articles poses a risk to human health for consumers and professional users that is not adequately controlled. It further concluded that, where there are articles exposing consumers and professional users to 2,4-DNT, the only way to manage the risk is to limit the presence of 2,4-DNT in the articles themselves. To this end, the dossier proposes to restrict the placing on the market and use of 2,4-DNT in articles for consumer and professional uses outside of industrial sites, given that, for those uses: (i) release of and exposure to 2,4-DNT cannot be excluded; and (ii) risk management measures are difficult to implement.